tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Allogene Therapeutics initiated with a Buy at UBS
PremiumThe FlyAllogene Therapeutics initiated with a Buy at UBS
2M ago
Allogene Therapeutics says favorable result for Servier in Cellectis arbitration
Premium
The Fly
Allogene Therapeutics says favorable result for Servier in Cellectis arbitration
3M ago
Allogene Therapeutics’ ALPHA Study: A Promising Update in CAR T Cell Therapy
Premium
Company Announcements
Allogene Therapeutics’ ALPHA Study: A Promising Update in CAR T Cell Therapy
3M ago
Allogene Therapeutics downgraded to Underweight from Neutral at JPMorgan
PremiumThe FlyAllogene Therapeutics downgraded to Underweight from Neutral at JPMorgan
5M ago
Allogene Therapeutics’ Promising Study on LBCL Treatment with Cema-cel
Premium
Company Announcements
Allogene Therapeutics’ Promising Study on LBCL Treatment with Cema-cel
6M ago
Allogene Therapeutics Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Allogene Therapeutics Earnings Call: Progress Amid Challenges
6M ago
Allogene Therapeutics reports Q2 EPS (23c), consensus (27c)
PremiumThe FlyAllogene Therapeutics reports Q2 EPS (23c), consensus (27c)
7M ago
Allogene Therapeutics options imply 16.7% move in share price post-earnings
Premium
The Fly
Allogene Therapeutics options imply 16.7% move in share price post-earnings
7M ago
Options Volatility and Implied Earnings Moves Today, August 13, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 13, 2025
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100